Skip to main content
. 2018 May 4;9(34):23608–23619. doi: 10.18632/oncotarget.25286

Table 1B. Tumour characteristics (n = 194).

Characteristics n %
Quadrant
 External 83 43
 Internal 77 40
 Central 29 15
 Unknown 5 2
Histology
 Invasive ductal carcinoma 162 85
 Invasive lobular carcinoma 15 8
 Carcinoma In situ 6 5
 Mixed (Ductal and lobular) 5 3
 Other 3 2
Clinical tumour stage
 cT1 102 53
 cT2 59 30
 cT3 24 12
 cT4 6 3
 Unknown 3 2
Clinical nodal stage
 cN0 93 48
 cN1 80 41
 cN2 1 1
 cN3 4 2
 Unknown 16 8
HER 2
 Yes 25 13
 No 163 84
 Unknown 6 3
Triple negative
 Yes 33 17
 No 155 80
 Unknown 6 3
HR+
 Yes 147 76
 No 41 21
 Unknown 6 3
SBR grade
 Low (I) 17 9
 Intermediate (II) 78 40
 High (III) 92 47
 Unknown 7 4

Abbreviations: HER 2 = human epidermal growth factor receptor 2; HR+ = Hormone receptor positive; SBR = Scarff-Bloom-Richardson.